Smoking and the consumption of antidepressants, anxiolytics and hypnotic drugs: Results of a large, French epidemiological study in 2005

Addictive Behaviors

Volumn 36, Issue 7, 2011, Pages 743-748

  Chéron Launay, Marie ^a   Le Faou, Anne Laurence ^b   Sévilla Dedieu, Christine ^c   Gilbert, Fabien ^c   Kovess Masfety, Viviane ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c MGEN Foundation for Public Health   (France)

Author keywords

Anxiety; Depressive disorder; Psychotropic drugs; Tobacco use cessation

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; DEPRESSION; FEMALE; HEALTH INSURANCE; HUMAN; MALE; PRESCRIPTION; REIMBURSEMENT; SMOKING; SMOKING CESSATION;

ADOLESCENT; ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; EPIDEMIOLOGIC STUDIES; FEMALE; FRANCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; SMOKING; YOUNG ADULT;

EID: 79954819869     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2011.02.013     Document Type: Article

References (29)

1. Beck F., Legleye S., Gautier A. Baromètre Santé 2005, attitudes et comportements de santé: INPES 2007.
2. Beck A.T., Rial W.Y., Rickels K. Short form of depression inventory: Cross-validation. Psychological Reports 1974, 34:1184-1186.
3. Breslau N. Psychiatric comorbidity of smoking and nicotine dependence. Behavior Genetics 1995, 25:95-101.
4. Breslau N., Peterson E.L., Schultz L.R., Chilcoat H.D., Andreski P. Major depression and stages of smoking. A longitudinal investigation. Archives of General Psychiatry 1998, 55:161-166.
5. Boffetta P., Pershagen G., Jockel K.H. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. Journal of the National Cancer Institute 1999, 91:697-701.
6. D'Aunno T., Vaughn T.E. Variations in methadone treatment practices. Results from a national study. JAMA 1992, 267:253-258.
7. Degenhardt L., Chiu W.T., Sampson N., Kessler R.C., Anthony J.C., Angermeyer M., Bruffaerts R., de Girolamo G., Gureje O., Huang Y., Karam A., Kostyuchenko S., Lepine J.P., Mora M.E., Neumark Y., Ormel J.H., Pinto-Meza A., Posada-Villa J., Stein D.J., Takeshima T., Wells J.E. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Medicine 2008, 5:e141.
8. Degenhardt L., Hall W. The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being. Nicotine & Tobacco Research 2001, 3:225-234.
9. Etter J.F., Duc T.V., Perneger T.V. Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction 1999, 94:269-281.
10. Farnam C.R., Zipple A.M., Tyrrell W., Chittinanda P. Health status risk factors of people with severe and persistent mental illness. Journal of Psychosocial Nursing and Mental Health Services 1999, 37:16-21.
11. Gache P., Michaud P., Landry U., Accietto C., Arfaoui S., Wenger O., Daeppen J.B. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: Reliability and validity of a French version. Alcoholism, Clinical and Experimental Research 2005, 29:2001-2007.
12. Gross J., Stitzer M.L. Nicotine replacement: Ten-week effects on tobacco withdrawal symptoms. Psychopharmacology (Berl) 1989, 98:334-341.
13. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 1986, 43:289-294.
14. INSERM Tabac, comprendre la dépendance pour agir 2004, Les éditions INSERM, Paris.
15. Irvine E.E., Bagnalasta M., Marcon C., Motta C., Tessari M., File S.E., Chiamulera C. Nicotine self-administration and withdrawal: Modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) 2001, 153:315-320.
16. Kovess V., Fournier L., Lesage A., Amiel-Lebigre F., Caria A. Two validation studies of the CIDIS: A simplified version of the CIDI. Psychiatric Networks 2001, 4:10-24.
17. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: A population-based prevalence study. JAMA 2000, 284:2606-2610.
18. Le Faou A.L., Scemama O., Ruelland A., Ménard J. Caractéristiques des fumeurs s'adressant aux consultations de tabacologie, analyse de la base nationale CDT. Revue des Maladies Respiratoires 2005, 22:739-750.
19. Lecadet J., Vidal P., Baris B., Vallier N., Fender P., Allemand H., Medipath G. Médicaments psychotropes: Consommations et pratiques de prescription en France métropolitaine. Données Nationales 2000. Revue médicale de l'Assurance Maladie 2003, 34:75-80.
20. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophrenia Research 1992, 8:93-102.
21. Mino Y., Shigemi J., Otsu T., Tsuda T., Babazono A. Does smoking cessation improve mental health?. Psychiatry and Clinical Neurosciences 2000, 54:169-172.
22. Pez O., Gilbert F., Bitfoi A., Carta M.G., Jordanova V., Garcia-Mahia C., Mateos-Alvarez R., Prince M., Tudorache B., Blatier C., Kovess-Masfety V. Validity across translations of short survey psychiatric diagnostic instruments: CIDI-SF and CIS-R versus SCID-I/NP in four European countries. Social Psychiatry and Psychiatric Epidemiology 2009, 45(12):1149-1159.
23. Picciotto M.R., Brunzell D.H., Caldarone B.J. Effect of nicotine and nicotinic receptors on anxiety and depression. NeuroReport 2002, 13:1097-1106.
24. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993, 88:791-804.
25. Tillmann M., Silcock J. A comparison of smokers' and ex-smokers' health-related quality of life. Journal of Public Health Medicine 1997, 19:268-273.
26. Tollier C., Fusier I., Husson M.C. ATC and EphMRA classifications: Evolution from 1996 to 2003 and comparative analysis. Thérapie 2005, 60:47-56.
27. Tsoh J.Y., Humfleet G.L., Munoz R.F., Reus V.I., Hartz D.T., Hall S.M. Development of major depression after treatment for smoking cessation. The American Journal of Psychiatry 2000, 157:368-374.
28. Walters E., al e Scoring the World Health Organization's Composite International Diagnostic Interview Short Form (CIDI-SF) 2002, Worlh Health Organization.
29. West R., Hajek P. What happens to anxiety levels on giving up smoking?. The American Journal of Psychiatry 1997, 154:1589-1592.